Jerome Groopman

Dr. Jerome Groopman is the Dina and Raphael Recanati Chair of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center, and a staff writer in medicine and biology at the New Yorker since 1998. He has identified growth factors which may restore the depressed immune systems of AIDS patients and treatments for AIDS-related neoplasms. In addition, Dr. Groopman has performed first clinical trials utilizing recombinant colony stimulating factors and erythropoietin to augment blood cell production in immunodeficient HIV-infected patients. He has contributed to the development of many AIDS-related therapies. Groopman has written editorials in The New Republic, The Washington Post and The New York Times and is the author of The Measure of Our Days (1997), Second Opinions: Stories of Intuition and Choice in the Changing World of Medicine (1998), Anatomy of Hope (2000) and How Doctors Think (2007). Currently, his basic laboratory research involves understanding how blood and vascular cells grow, communicate, and migrate. He is also studying how viruses cause immune deficiency and cancer, the role of encocannabinoids in hematopoiesis, mechanisms of liver injury due to hepatitis C virus, and the effects of novel cell cycle inhibitors against mantle cell lymphoma.